nVerses Capital’s Alkermes ALKS Stock Holding History

nVerses Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,100	Closed	-$83.9K	–	988
2024 Q1	$83.9K	Buy	+3,100	New	+$88K	0.2%	199

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

nVerses Capital's ALKS Position: Q2 2024 in Review

nVerses Capital sold out of Alkermes (ALKS) in Q2 2024, closing a stake of 3,100 shares — an estimated $83.9K sold.

nVerses Capital first reported a position in ALKS in Q1 2024 and held it in 1 quarter. The position peaked at $83.9K in Q1 2024. 322 funds tracked by Wall St. Rank hold ALKS as of Q2 2024.

nVerses Capital reported no remaining Alkermes position as of Q2 2024 after selling out during the quarter.
nVerses Capital sold 3,100 Alkermes shares in Q2 2024, an estimated $83.9K.
nVerses Capital first reported a position in Alkermes in Q1 2024 and held it in 1 quarter.
nVerses Capital's Alkermes position peaked at $83.9K in Q1 2024.
322 funds tracked by Wall St. Rank held Alkermes as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.